Jan . 22, 2024 11:11 Back to list

crazy paving-how to fill gaps in crazy paving

CASE REPORT

An 18-year-old female student, a never smoker, HIV-negative, was referred to our Institute for evaluation of exertional breathlessness, cough with minimal mucoid sputum and fever of 1.5 years duration. She had lost 15 kg weight over the past 6 months. Prior to the presentation, based on her clinical and radiological profile, she had received antituberculous therapy for 4 months with no relief.

On examination, she was tachypnoeic and dyspnoeic but afebrile. Digital clubbing was observed. Vesicular breath sounds with fine inspiratory crackles were audible in all areas of the chest wall. Oxygen saturation on room air was 54%. Arterial blood gas analysis on oxygen (4 lt/min) showed pH 7.40, PCO₂38.7 mmHg, PO₂57.6 mmHg, and SaO₂ of 90%. The total leucocyte count was 5.43 × 10³ cells/μL with a normal differential count.

Chest radiograph is shown in Figure 1 and high resolution computed tomography (HRCT) of the thorax is shown in Figure 2. Sputum stains and cultures for Mycobacterium tuberculosis, fungi and other aerobic organisms were negative. Fiber-optic bronchoscopy did not visualize any gross abnormality. Bronchoalveolar lavage (BAL) was milky in appearance but stains and cultures were negative for aerobic organisms including M. tuberculosis and pathogenic fungi. The BAL fluid was sent for a special investigation.

Granulocyte-macrophage colony stimulating factor (GM-CSF) supplemental therapy has a role in the management of idiopathic PAP.[9] GM-CSF therapy can be given either by inhaled or subcutaneous route and it can be considered supplemental to WLL with response rates of 50%[9]
Newer modalities of treatment include administration of Rituximab, a monoclonal antibody directed against the CD20 antigen of B-lymphocytes. It helps in decreasing the concentration of anti-GM-CSF antibodies through the depletion of B-cells.[4] Rituximab is useful in patients not responsive to WLL or GM-CSF therapy. Plasmapheresis is a novel technique which involves removal of the anti-GM CSF antibodies. It leads to improvement in symptoms, oxygen saturation and radiological appearance. Lung transplantation has been attempted in patients with congenital PAP.[4]

Irregular stones

DISCUSSION

PAP, first described in 1958 by Rosen et al.,[10] is a distinct clinical entity with an estimated prevalence of 0.1 case per 100,000 individuals.[8] This disorder is characterized by intraalveolar accumulation of lipo-proteinaceous material due to defective clearing by the alveolar macrophages. Three distinct subtypes have been recognized: Auto-immune (idiopathic), secondary, and congenital. The auto-immune (idiopathic) form, seen in 90% of the patients, is the most common subtype.[11] Anti-GM-CSF antibodies plays a central role in the pathogenesis of auto-immune (idiopathic) subtype while secondary type is seen in various pulmonary infections, hematological malignancies, and industrial dust exposure.[6]

Chest radiography, a useful screening test, shows a typical perihilar or “batwing” distribution of alveolar opacities. These findings can be confused with those of pulmonary edema, however, absence of cardiomegaly, pleural effusion, Kerley-B lines on chest radiograph usually rules in the favor of PAP. Other less common radiological abnormalities include reticular or reticulonodular shadows, multifocal consolidation, or ground-glassing.[4] The first ever description of “Crazy-paving” pattern on HRCT was in a patient of PAP[12] and has been considered as a hallmark of the disease. HRCT shows areas of patchy alveolar opacification with superimposition of a network of reticulations. These areas of air-space opacification, seen as GGO, are clearly demarcated from the surrounding normal lung parenchyma.[1,4]"Crazy-paving" pattern results from a combination of these reticular networks and GGO. These reticular networks are due to the interlobular, as well as intralobular septal thickening[4] or due to deposition of material in the alveoli at the borders of the acini (periacinar pattern)[3] while the GGO occur due to deposition of PAS-positive material in the alveoli.[4] Together these resemble a pavement lined with irregular shaped stones laid in a polygonal fashion. Apart from the characteristic “Crazy-paving” pattern, other features seen on HRCT include interlobular septal thickening and GGOs without “Crazy-paving” pattern, diffuse bilateral GGOs without septal thickening, consolidation, pulmonary nodules, mediastinal lymphadenopathy, and pleural effusion.[13]

BAL has an important supportive role in the diagnosis of PAP. It has a milky appearance due to the presence of lipo-proteinaceous material consisting of phospholipids and surfactant proteins. On staining the BAL fluid, the presence of PAS-positive, eosinophilic, granular, acellular material with occasional enlarged foamy macrophages generally establishes the diagnosis. OLB reveals the deposition of PAS-positive, eosinophilic material within the alveoli without any architectural distortion.[6] Detection of anti-GM-CSF antibodies is an important tool for differentiating autoimmune (idiopathic) form from other subtypes of PAP with a high sensitivity and specificity.

Pulmonary alveolar proteinosis in India

A search of the literature on the subject from India using the PubMed, IndMed databases and Google revealed 25 reports documenting 30 patients of PAP. All 30 documented patients from India were reviewed and are tabulated in Table 2.

The first documented report of PAP from India was in a 35-year-old man, a sailor from the armed forces.[14] Of the 30 patients, 22 were males (73%) and the age group varied from 4 months to 54 years in males while in female patients ranged from 18 months to 58 years. There were six patients in the pediatric age group[15,17,24,33,36,37] with four of them being males.[15,17,24,36] Cough and dyspnea were the predominant presenting symptoms seen in almost all patients. Respiratory failure, on presentation, was noted in 9/30 patients (30%).[24,25,27,32,35,37] Our patient too presented with type I respiratory failure. Of the 26 patients[14,16,18,20,21,22,23,24,25,27,28,29,30,31,32,33,34,35,36,37,38] in whom CT chest was performed, HRCT was done in 23.[14,16,18,20,21,22,23,27,28,29,30,31,32,33,34,35,37,38] Characteristic “Crazy-paving” pattern was documented in 18 of them.[18,21,22,23,27,28,29,30,31,32,33,34,37,38] Bilateral “Crazy-paving” was seen in 14/18 patients.[18,21,22,23,27,28,29,30,31,32,34,37,38] Information regarding the distribution of “Crazy-paving” was not available in 4 patients.[27,33] Our patient too had a distinctive bilateral “Crazy-paving” pattern on HRCT. In 16/30 patients information regarding classification either as idiopathic or secondary was not available.[15,16,17,18,19,20,22,23,24,25,29,32,33,34,37,38] The disease was classified as idiopathic in 9/30 patients[21,27,28,30,31] and in five patients as secondary PAP.[14,26,28,35,36] Our patient too was classified as idiopathic.

Diagnosis was established by cytopathological examination and staining of the BAL fluid in 6/30 patients[17,18,20,30,34,37] while in a pediatric patient, tracheal aspirate was used to confirm the diagnosis.[36] In another seven patients, apart from BAL additional transbronchial biopsy was done.[15,22,28,31,32,33,38] OLB was confirmatory in 11/30 patients[14,16,21,23,24,27,28,31] and in one patient video assisted thoracoscopic lung biopsy was done.[29] Autopsy proved the diagnosis in one patient.[26] In three patients information regarding the diagnostic modality was not available.[19,25,33]

WLL as a therapeutic modality was used in 18/30 patients[17,19,20,21,22,23,25,27,28,29,31,32,36,37,38] while serial lobar lung lavage was done in one patient.[30] Of these 18 patients, seven in addition received GM-CSF therapy.[28,29,30,32,37] GM-CSF therapy alone as a treatment modality was used in one patient.[28] In all patients who had undergone WLL, response to therapy was considered to be satisfactory.[17,19,20,21,22,23,25,27,28,29,31,32,36,37,38] In patients who had received GM-CSF therapy in addition to WLL, it could not be ascertained whether the response to therapy was due to WLL or due to GM-CSF.[28,29,30,32,37] The only patient who had received GM-CSF therapy alone showed clinical response but had no radiological improvement.[28] One patient who was symptomatic even after five sessions of WLL showed significant benefit post-GM-CSF therapy.[29] Repeated bronchoscopic lavage was the treatment modality in two patients[24,34] of whom one died.[24] Conservative management was done in five patients[16,26,28,33,35] with mortality seen in one patient.[26] Treatment resulted in remarkable improvement in 25/30 patients.[16,17,19,20,21,22,23,25,27,28,29,30,31,32,33,34,35,36,37,38] In one patient, information regarding the treatment modality was not available[18] while two other patients were lost to follow-up.[14,15] Our patient too was lost to follow-up.

PAP is rare but a distinct clinical entity and presents characteristically with “Crazy-paving” pattern on HRCT. In India, PAP does not appear to be as rare as initially thought and state of the art therapy has been administered with gratifying results.

Financial support and sponsorship

crazy paving-Radiological Finding of Crazy-Paving Pattern in COVID-19 Pneumonia